The day before the European Union announced that AstraZeneca vaccine was related to thrombosis, Oxford University stopped the small-scale clinical trial of AstraZeneca COVID-19 vaccine in British children and adolescents. In addition, Oxford University also argues that the experiment that has been conducted is safe. Considering the possible risks, the project has been suspended and is waiting for more data from the EU. However, AstraZeneca still advocates the safety of this vaccine, and there is no clear evidence that this vaccine has anything to do with the bloody battle of the vaccinators.
The European Medicines Agency said that at that time, 5 million people in Europe had been vaccinated with AstraZeneca vaccine, but only more than 30 cases of thrombosis were reported. He also argued: "There is no indication that vaccination will lead to this situation. This situation is not a side effect of this vaccine. " Therefore, the advantages of this vaccine still outweigh the disadvantages. While we continue to investigate, people can continue to vaccinate this vaccine. Savina Strauss, Chairman of the Evaluation Committee of the European Medicines Agency (EMA), reported at a news conference that after AstraZeneca vaccination, Europe and other countries were engaged in a bloody battle. This is a very rare side effect of vaccination. The European Medicines Agency (EMA) Committee will also conduct further investigation to study and confirm the specific risk factors of side effects. A person from the European medical office said that according to the current spreading power of the new coronavirus, the death probability caused by the virus is far greater than the death rate caused by the side effects of vaccination. Generally speaking, the advantages of AstraZeneca vaccination outweigh the disadvantages.
The World Health Organization's Global Vaccine Safety Advisory Committee said that although AstraZeneca vaccination has thrombosis, the probability of this incident is extremely low. According to the inoculated samples, the number of infected thrombi is very small, and then stricter investigation and control will be carried out to solve any safety problems. On the other hand, the European Medicines Agency said that if you have difficulty breathing, abdominal pain, chest pain, leg swelling and other phenomena, you should go to the hospital in time.